AAAAAA

   
Results: 1-25 |
Results: 25
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study
Authors: Carella, AM Cascavilla, N Greco, MM Melillo, L Sajeva, MR Ladogana, S D'Arena, G Perla, G Carotenuto, M
Citation: Am. Carella et al., Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study, LEUK LYMPH, 40(3-4), 2001, pp. 295-303
Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia
Authors: Carella, AM
Citation: Am. Carella, Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia, LEUK LYMPH, 40(3-4), 2001, pp. 447-448
Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease
Authors: Carella, AM Beltrami, G Carella, M Corsetti, MT Scalzulli, RP Greco, M
Citation: Am. Carella et al., Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease, HAEMATOLOG, 86(11), 2001, pp. 1121-1123
Expansion of hematogones in a patient with Gaucher disease
Authors: D'Arena, G Bisceglia, M Ladogana, S Carella, AM Carotenuto, M Paolucci, P
Citation: G. D'Arena et al., Expansion of hematogones in a patient with Gaucher disease, MED PED ONC, 36(6), 2001, pp. 657-658
Hodgkins disease
Authors: Ferme, C Cosset, JM Fervers, B Sebban, C Cutuli, B Henry-Amar, M Stines, J Giammarile, F Bey, P Carella, AM Philip, T
Citation: C. Ferme et al., Hodgkins disease, BR J CANC, 84, 2001, pp. 55-60
Minimally differentiated acute myeloid leukemia (AML MO): Clinico-biological findings of 29 cases
Authors: Cascavilla, N Melillo, L D'arena, G Greco, MM Carella, AM Sajeva, MR Perla, G Matera, R Minervini, MM Carotenuto, M
Citation: N. Cascavilla et al., Minimally differentiated acute myeloid leukemia (AML MO): Clinico-biological findings of 29 cases, LEUK LYMPH, 37(1-2), 2000, pp. 105-113
Autografting with non-clonal mobilized hematopoietic progenitor cells in CML
Authors: Carella, AM
Citation: Am. Carella, Autografting with non-clonal mobilized hematopoietic progenitor cells in CML, LEUKEMIA, 14(5), 2000, pp. 954-955
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma
Authors: Carella, AM Cavaliere, M Lerma, E Ferrara, R Tedeschi, L Romanelli, A Vinci, M Pinotti, G Lambelet, P Loni, C Verdiani, S De Stefano, F Valbonesi, M Corsetti, MT
Citation: Am. Carella et al., Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma, J CL ONCOL, 18(23), 2000, pp. 3918-3924
Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia
Authors: Carella, AM Giralt, S Slavin, S
Citation: Am. Carella et al., Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia, HAEMATOLOG, 85(3), 2000, pp. 304-313
Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft (vol 28, pg 104, 2000)
Authors: Corsetti, MT Lerma, E Dejana, A Cavaliere, M Figari, O Vassallo, F Abate, M Luchetti, S Piaggio, G Parodi, C Li Pira, G Manca, F Carella, AM
Citation: Mt. Corsetti et al., Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft (vol 28, pg 104, 2000), EXP HEMATOL, 28(3), 2000, pp. 353-353
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis
Authors: Podesta, M Piaggio, G Sessarego, M Pitto, A Figari, O Soracco, M Carella, AM Dejana, A Rosti, V Fugazza, G Ravera, G Lerma, E Cazzola, M Bacigalupo, A Frassoni, F
Citation: M. Podesta et al., Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis, EXP HEMATOL, 28(2), 2000, pp. 210-215
Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft
Authors: Corsetti, MT Lerma, E Dejana, A Cavaliere, M Figari, O Vassallo, F Abate, M Luchetti, S Piaggio, G Parodi, C Pira, GL Manca, F Carella, AM
Citation: Mt. Corsetti et al., Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft, EXP HEMATOL, 28(1), 2000, pp. 104-111
Mini-allografts: ongoing trials in humans
Authors: Carella, AM Champlin, R Slavin, S McSweeney, P Storb, R
Citation: Am. Carella et al., Mini-allografts: ongoing trials in humans, BONE MAR TR, 25(4), 2000, pp. 345-350
Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation
Authors: Simonsson, B Totterman, T Hokland, P Lauria, F Carella, AM Fernandez, MN Rozman, C Ferrant, A de Witte, T Zander, AR Meier, K Hansson, F
Citation: B. Simonsson et al., Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation, BONE MAR TR, 25(11), 2000, pp. 1121-1127
Autografting followed by low-intensity conditioning regimen for allografting
Authors: Carella, AM
Citation: Am. Carella, Autografting followed by low-intensity conditioning regimen for allografting, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 569-574
Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia
Authors: Carella, AM Cavaliere, M Lerma, E Corsetti, MT
Citation: Am. Carella et al., Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia, BAIL CLIN H, 12(1-2), 1999, pp. 209-217
Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia
Authors: Corsetti, MT Lerma, E Dejana, A Basta, P Ferrara, R Benvenuto, F Vassallo, F Abate, M Piaggio, G Parodi, C Sessarego, M Pira, GL Manca, F Carella, AM
Citation: Mt. Corsetti et al., Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia, LEUKEMIA, 13(7), 1999, pp. 999-1008
Standards, options and recommendations for the management of patients withHodgkin's disease
Authors: Ferme, C Cosset, JM Fervers, B Sebban, C Cutuli, B Henry-Amar, M Stines, J Giammarile, F Bey, P Carella, AM Philip, T
Citation: C. Ferme et al., Standards, options and recommendations for the management of patients withHodgkin's disease, PRESSE MED, 28(40), 1999, pp. 2233-2242
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation
Authors: Sweetenham, JW Carella, AM Taghipour, G Cunningham, D Marcus, R Della Volpe, A Linch, DC Schmitz, N Goldstone, AH
Citation: Jw. Sweetenham et al., High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation, J CL ONCOL, 17(10), 1999, pp. 3101-3109
Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: Temporal relationship with growth hormone (GH) levels
Authors: Mazzoccoli, G Giuliani, A Bianco, G De Cata, A Balzanelli, M Carella, AM La Viola, M Tarquini, R
Citation: G. Mazzoccoli et al., Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: Temporal relationship with growth hormone (GH) levels, ANTICANC R, 19(2B), 1999, pp. 1397-1399
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time
Authors: Frassoni, F Podesta, M Piaggio, G Rosti, V Pitto, A Benvenuto, F Figari, O Vassallo, F Carella, AM Zikos, P Bergamaschi, G Fugazza, G Sessarego, M Cazzola, M
Citation: F. Frassoni et al., Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time, BR J HAEM, 104(3), 1999, pp. 538-545
Comparative analysis of autografting in chronic myelogenous leukemia: Effect of priming regimen and marrow or blood origin of stem cells
Authors: Carella, AM
Citation: Am. Carella, Comparative analysis of autografting in chronic myelogenous leukemia: Effect of priming regimen and marrow or blood origin of stem cells, BLOOD, 93(6), 1999, pp. 2136-2137
Autografting with Philadelphia chromosome-negative mobilized hematopoieticprogenitor cells in chronic myelogenous leukemia
Authors: Carella, AM Lerma, E Corsetti, MT Dejana, A Basta, P Vassallo, F Abate, M Soracco, M Benvenuto, F Figari, O Podesta, M Piaggio, G Ferrara, R Sessarego, M Parodi, C Pizzuti, M Rubagotti, A Occhini, D Frassoni, F
Citation: Am. Carella et al., Autografting with Philadelphia chromosome-negative mobilized hematopoieticprogenitor cells in chronic myelogenous leukemia, BLOOD, 93(5), 1999, pp. 1534-1539
Role of bone marrow transplantation in Hodgkin's disease
Authors: Armitage, JO Goldstone, AH Carella, AM Schmitz, N Phillips, GL Bierman, PJ
Citation: Jo. Armitage et al., Role of bone marrow transplantation in Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 521-530
Mini-ICE protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia
Authors: Carella, AM
Citation: Am. Carella, Mini-ICE protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 437-438
Risultati: 1-25 |